Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Shanghai ChemPartner, a China CRO/CMO, Completes Reverse Merger
Week in Review: Shanghai Junshi Biosciences Files for $500 Million Hong Kong IPO
Week in Review: Two Hong Kong IPO - BeiGene and Ascletis - Raise a Combined $1.3 Billion
Laekna Acquires Exclusive Worldwide Rights to Two Clinical Stage Oncology Assets
Week in Review: Long Hill Capital Closes $265 Million Fund for China Healthcare
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event

Device China 2018
September 8-9, 2018